(lp0
S"ACADIA Pharma Looks Like A Take-Out Target Seeking Alpha - Feb 27, 2017 But one company in particular has this San Diegan very interested. The company I'm talking about is ACADIA Pharmaceuticals , and in a field of speculative, pre-FDA-approval pharma companies, ACADIA has potential few others possess."
p1
aS"Don't Be So Sure ACADIA Wants To Sell Seeking Alpha - Mar 7, 2017 I have owned for myself and the Clients of Mott Capital Management, LLC shares of ACADIA Pharmaceuticals  for well over two years now.ACADIA Pharmaceuticals Inc  Has A Problem With Nuplazid - BNL Finance   ACADIA Pharmaceuticals Inc. : What's the Story? - StockNewsJournal"
p2
aS"Analyst's Predictions on ACADIA Pharmaceuticals Inc. , Santander ... StockNewsJournal - Mar 20, 2017 ACADIA Pharmaceuticals Inc.  have shown a high EPS growth of -40.00% in the last 5 years and has earnings decline of -43.30% yoy."
p3
aS'Earnings Reaction History: ACADIA Pharmaceuticals Inc, 50.0% Follow-Through ... Nasdaq - Feb 28, 2017 ACADIA Pharmaceuticals Inc  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement ...'
p4
aS'ACADIA Pharmaceuticals Inc.  Upgraded at Zacks Investment Research The Cerbat Gem - 14 hours ago Zacks Investment Research upgraded shares of ACADIA Pharmaceuticals Inc.  from a sell rating to a hold rating in a research note released on Friday.'
p5
aS'ACADIA Pharmaceuticals Inc. , Achillion Pharmaceuticals, Inc. (ACHN ... The USA Commerce - 15 hours ago Presently ACADIA Pharmaceuticals Inc.  stock have an ABR of 1.75. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.'
p6
aS'ACADIA: A Buyout Remains Most Likely Scenario Seeking Alpha - Mar 3, 2017 ACADIA Pharmaceuticals has surged ahead some 80% over the past year thanks to the FDA approval of Nuplazid, the first drug to be approved for the psychosis associated with Parkinsons.'
p7
aS'Checking the Chart on Shares of ACADIA Pharmaceuticals Inc  The Standard - 11 hours ago ACADIA Pharmaceuticals Inc  has a current 14 day Williams %R reading of -90.26. Levels can range from 0 to -100. A Williams %R that falls between -80 to -100 is typically viewed as being in strong oversold territory.'
p8
aS'Iceberg Ahead With Valeant Pharmaceuticals Intl Inc  Weak Guidance ... Smarter Analyst - Mar 1, 2017 Valeant Pharmaceuticals Intl Inc  has Canaccord worried after releasing 2017 financial guidance yesterday morning that came up short of already subdued expectations.'
p9
aS"ACADIA Pharma  Q4 Earnings: What's in Store this Time? Yahoo Finance - Feb 23, 2017 The company's track record is dismal. ACADIA has missed estimates in all the trailing four quarters, bringing the average negative earnings surprise to 19.07%."
p10
a.